Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
6.13
+0.25 (4.25%)
At close: Mar 12, 2026, 4:00 PM EDT
6.12
-0.01 (-0.11%)
After-hours: Mar 12, 2026, 6:54 PM EDT
Shattuck Labs Revenue
In the year 2025, Shattuck Labs had annual revenue of $2.00M, down -82.52%. Shattuck Labs had revenue of $-1.00M in the quarter ending December 31, 2025.
Revenue (ttm)
$2.00M
Revenue Growth
-82.52%
P/S Ratio
438.69
Revenue / Employee
$22,727
Employees
44
Market Cap
438.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.00M | -9.44M | -82.52% |
| Dec 31, 2024 | 11.44M | 9.79M | 590.53% |
| Dec 31, 2023 | 1.66M | 1.01M | 154.14% |
| Dec 31, 2022 | 652.00K | -29.37M | -97.83% |
| Dec 31, 2021 | 30.02M | 20.08M | 202.16% |
| Dec 31, 2020 | 9.93M | 47.00K | 0.48% |
| Dec 31, 2019 | 9.89M | -12.56M | -55.94% |
| Dec 31, 2018 | 22.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sutro Biopharma | 105.65M |
| Lineage Cell Therapeutics | 14.56M |
| Crescent Biopharma | 10.84M |
| PureTech Health | 6.39M |
| Immutep | 5.28M |
| 4D Molecular Therapeutics | 120.00K |
| vTv Therapeutics | 17.00K |
STTK News
- 7 days ago - Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 15 days ago - Shattuck Labs Announces Participation in Upcoming March Investor Conferences - GlobeNewsWire
- 4 weeks ago - Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium - GlobeNewsWire
- 3 months ago - Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Analyst Upgrade Boosts Shattuck On Confidence In Next-Gen Inflammatory Bowel Disease Therapy - Benzinga
- 4 months ago - Shattuck Labs to Participate in Upcoming December Investor Conferences - GlobeNewsWire
- 4 months ago - Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 5 months ago - Shattuck Labs, Inc. (STTK) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript - Seeking Alpha